Revenues of Vitro Biopharma, Inc. from 31 Oct 2013 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Vitro Biopharma, Inc. quarterly and annual Revenues in USD history and change rate from 31 Oct 2013 to 31 Oct 2025.
  • Vitro Biopharma, Inc. Revenues for the quarter ending 31 Oct 2025 was $486,717, a 9.6% decline year-over-year.
  • Vitro Biopharma, Inc. Revenues for the twelve months ending 31 Oct 2025 was $2,056,818, a 11% increase year-over-year.
  • Vitro Biopharma, Inc. annual Revenues for 2025 was $2,056,818, a 11% increase from 2024.
  • Vitro Biopharma, Inc. annual Revenues for 2024 was $1,855,644, a 5.2% increase from 2023.
  • Vitro Biopharma, Inc. annual Revenues for 2023 was $1,763,451.
Source SEC data
View on sec.gov
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)

Vitro Biopharma, Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,056,818 $486,717 -$51,871 -9.6% 01 Aug 2025 31 Oct 2025 10-K 13 Feb 2026 2025 FY
Q2 2025 $2,108,689 $608,643 +$288,734 +90% 01 May 2025 31 Jul 2025 10-Q 12 Sep 2025 2025 Q3
Q1 2025 $1,819,955 $511,584 -$61,353 -11% 01 Feb 2025 30 Apr 2025 10-Q 20 Jun 2025 2025 Q2
Q4 2024 $1,881,308 $449,874 +$25,664 +6% 01 Nov 2024 31 Jan 2025 10-Q 20 Mar 2025 2025 Q1
Q3 2024 $1,855,644 $538,588 +$4,251 +0.8% 01 Aug 2024 31 Oct 2024 10-K 13 Feb 2026 2025 FY
Q2 2024 $1,851,393 $319,909 -$257,331 -45% 01 May 2024 31 Jul 2024 10-Q 12 Sep 2025 2025 Q3
Q1 2024 $2,108,724 $572,937 +$265,094 +86% 01 Feb 2024 30 Apr 2024 10-Q 20 Jun 2025 2025 Q2
Q4 2023 $1,843,630 $424,210 +$80,179 +23% 01 Nov 2023 31 Jan 2024 10-Q 20 Mar 2025 2025 Q1
Q3 2023 $1,763,451 $534,337 01 Aug 2023 31 Oct 2023 10-K 28 Jan 2025 2024 FY
Q2 2023 $577,240 01 May 2023 31 Jul 2023 10-Q 16 Sep 2024 2024 Q3
Q1 2023 $307,843 01 Feb 2023 30 Apr 2023 10-Q 31 May 2024 2024 Q2
Q4 2022 $344,031 -$812,325 -70% 01 Nov 2022 31 Jan 2023 10-Q 14 Mar 2024 2024 Q1
Q4 2021 $1,156,356 01 Nov 2021 31 Jan 2022 10-Q 14 Mar 2023 2023 Q1
Q1 2015 $20,400 -$7,211 -26% 01 Feb 2015 30 Apr 2015 10-Q 22 Jan 2016 2015 Q2
Q4 2014 $14,484 -$10,184 -41% 01 Nov 2014 31 Jan 2015 10-Q 24 Mar 2015 2015 Q1
Q1 2014 $27,611 01 Feb 2014 30 Apr 2014 10-Q 22 Jan 2016 2015 Q2
Q4 2013 $24,668 01 Nov 2013 31 Jan 2014 10-Q 24 Mar 2015 2015 Q1

Vitro Biopharma, Inc. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $2,056,818 +$201,174 +11% 01 Nov 2024 31 Oct 2025 10-K 13 Feb 2026 2025 FY
2024 $1,855,644 +$92,193 +5.2% 01 Nov 2023 31 Oct 2024 10-K 13 Feb 2026 2025 FY
2023 $1,763,451 01 Nov 2022 31 Oct 2023 10-K 28 Jan 2025 2024 FY
2015 $77,801 -$41,917 -35% 01 Nov 2014 31 Oct 2015 10-K 22 Sep 2016 2015 FY
2014 $119,718 +$96,769 +422% 01 Nov 2013 31 Oct 2014 10-K 22 Sep 2016 2015 FY
2013 $22,949 01 Nov 2012 31 Oct 2013 10-K 13 Feb 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.